{
    "cancelStatus": "0",
    "cancelDate": null,
    "cancelReason": [],
    "licid": "91000854",
    "validDate": "2028-08-30 00:00:00.000",
    "issueDate": "2018-08-30 00:00:00.000",
    "licKind": "10",
    "oldLicid": null,
    "certNo": "DHA09100085404",
    "prodNameC": "思利馬林",
    "prodNameE": "SILYMARIN",
    "indicationsName": [
        "肝臟機能障礙劑"
    ],
    "does": "0040",
    "packageUnit": [
        {
            "packageSpec": "",
            "packageUnit": "4C"
        }
    ],
    "medMCode": "01",
    "maMedCode": "",
    "medDCode": "E",
    "ingredientsDesc": [
        "Silymarin-mixture of the isomers silibinin, silicristin and silidianin:(C25H22O10)\r\n\r\n1.Assay of Silymarin, determined as silibinin, per cent:From 30 to 65\r\n2.Sum of silidianin and silicristin, per cent the total content of silymarin:From 20 to 45\r\n3.Sum of silibianin A and silibianin B, per cent the total content of Silymarin:From 40 to 65\r\n4.Sum of isosilibinin A and isosilibinin B, per cent the total content of silymarin:From 10 to 20"
    ],
    "restraintItemsCode": [
        "02",
        "40"
    ],
    "applicantName": "龍大生技股份有限公司",
    "applicantAddr": "台南市中西區民權路二段158號3樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "LIVERD PHARMA CO., LTD ",
            "factoryAddr": "GAOSHENG ECONOMIC ZONE, PANJIN CITY, LIAONING, CHINA ",
            "factoryCompanyAddr": "",
            "countryCode": "CN",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FCN1178000",
            "factoryInfo": null,
            "qsd": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsDesc": "Silymarin-mixture of the isomers silibinin, silicristin and silidianin:(C25H22O10)\r\n\r\n1.Assay of Silymarin, determined as silibinin, per cent:From 30 to 65\r\n2.Sum of silidianin and silicristin, per cent the total content of silymarin:From 20 to 45\r\n3.Sum of silibianin A and silibianin B, per cent the total content of Silymarin:From 40 to 65\r\n4.Sum of isosilibinin A and isosilibinin B, per cent the total content of silymarin:From 10 to 20",
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "2"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [
        {
            "licChgDocId": "602F48BB-A74D-4897-9553-7F679D03792D",
            "approvedDocNo": "9999999999",
            "approvedDate": "2022-03-14",
            "changeItem": null,
            "changeRecord": null,
            "remark": ""
        },
        {
            "licChgDocId": "FC0FF9EB-7757-44A1-BCA2-F9BCA6A895E7",
            "approvedDocNo": "9999999999",
            "approvedDate": "2019-03-15",
            "changeItem": null,
            "changeRecord": null,
            "remark": ""
        }
    ],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "A05BA03"
        }
    ],
    "licBaseId": "8D754A43-0616-4136-BA55-9644B64CFA36"
}